Skip to the answer

Loncastuximab Tesirine-lpyl Injection Uses, Dosage, Side Effects and Interactions

Brand name
Zynlonta

Zynlonta is a brand of loncastuximab tesirine-lpyl injection that comes as an injection.

Loncastuximab tesirine-lpyl (Zynlonta) is an intravenous cancer medicine used for adults whose large B-cell lymphoma has come back or has not responded after two or more earlier treatments.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Loncastuximab Tesirine-lpyl InjectionType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Loncastuximab Tesirine-lpyl Injection in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Zynlonta is a later-line drug for adults whose large B-cell lymphoma came back or stopped responding after two or more treatments. It is an antibody that latches onto CD19 on B cells and carries a DNA-damaging drug inside them, on the market since 2021 and not available as a generic. For a lymphoma treatment it is fairly manageable, and what people notice most is tiredness, swelling, nausea and rash or sun sensitivity. The thing to watch is fluid buildup, so report new swelling, rapid weight gain or shortness of breath promptly, and treat any fever as urgent because low blood counts make infections dangerous. Your team will check blood counts and liver tests throughout.

Key Takeaways From the HelloPharmacist Team

  • Expect a 30-minute IV infusion at the clinic every 3 weeks, with a lower dose after the first two cycles.
  • Take the steroid dexamethasone for 3 days, starting the day before each infusion, unless your doctor tells you otherwise.
  • Cover up and use sunscreen outdoors, and avoid sun even through windows, since Zynlonta can cause sunburn-like skin reactions.
  • If pregnancy is possible, use effective birth control during treatment and for 10 months after for women, or 7 months for men.

How we write and review this content: our editorial policy

Loncastuximab Tesirine-lpyl Injection by the Numbers

Strengths
1
in one form
Makers and packagers
1
Earliest FDA record
2021
Rank by Medicaid prescriptions
#1,644 of 1,682 drugs
More prescriptions than 2% of the 1,682 drugs we measure
32 prescriptions, Q1–Q4 2025

Patient Information Guide for Loncastuximab Tesirine-lpyl Injection

What It’s Used For

Loncastuximab tesirine-lpyl is used to treat a type of lymphoma in adults.

  • ZYNLONTA (intravenous) treats relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.
  • This includes DLBCL not otherwise specified, DLBCL arising from low-grade lymphoma, and high-grade B-cell lymphoma.
  • It was approved under accelerated approval based on response rate, and continued approval may depend on confirmatory trials.

How It Works

Loncastuximab tesirine-lpyl is an antibody-drug conjugate. The antibody portion binds to CD19, a protein on B cells. Once attached, the drug is taken into the cell and releases SG3199, which damages DNA and causes cell death. It showed anticancer activity in animal models of lymphoma.

Drug Class

WHO drug family

  • Other monoclonal antibodies and antibody drug conjugates
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)

None. The FDA’s index lists no class of any kind for Loncastuximab Tesirine-lpyl Injection.

The main drug class the FDA gives it. It is the class named on the drug’s label.

What It Does in the Body

Physiologic effect (PE)

None listed for Loncastuximab Tesirine-lpyl Injection in the FDA’s index.

From our Patient Information GuideLoncastuximab tesirine-lpyl is an antibody-drug conjugate. The antibody portion binds to CD19, a protein on B cells. Once attached, the drug is taken into the cell and releases SG3199, which damages DNA and causes cell death. Read How Loncastuximab Tesirine-lpyl Injection Works

A change it makes in how the body works.

Drug Family

WHO ATC classification
  • Other monoclonal antibodies and antibody drug conjugates

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.

Dosage

ZYNLONTA is given by a healthcare professional as a 30-minute infusion into a vein, on Day 1 of each 3-week cycle. The dose is higher for the first two cycles and lower afterward.

  • A steroid (dexamethasone) is taken for 3 days, starting the day before each infusion, unless it is not appropriate.
  • Treatment may be delayed or the dose reduced if side effects occur.
  • Your care team will tell you what to do if an appointment is missed.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Large B-cell lymphoma that came back or did not respond to treatment

Adults · Cycles 1 and 2 Starting dose 0.15 mg/kg every 3 weeks
  • 0.15 mg/kg every 3 weeks for 2 cycles, as an intravenous infusion over 30 minutes on Day 1 of each cycle
Adults · Later cycles Usual dose 0.075 mg/kg every 3 weeks
  • 0.075 mg/kg every 3 weeks for subsequent cycles, as an intravenous infusion over 30 minutes on Day 1 of each cycle

Good to know

For patients with BMI ≥35 kg/m2, dose is calculated on adjusted body weight

BMI stands for body mass index.

Adults · Premedication Usual dose 4 mg of dexamethasone twice a day
  • Dexamethasone 4 mg orally or intravenously twice daily for 3 days beginning the day before Zynlonta

Good to know

If not begun the day before, start dexamethasone at least 2 hours before Zynlonta

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects, including lab changes, are:

Common side effects

  • Low platelets, neutrophils or red blood cells
  • Raised liver tests (GGT, AST, ALT)
  • Tiredness
  • Rash, itching or sun sensitivity
  • Swelling (edema)
  • Nausea
  • Muscle or bone pain
  • High blood sugar
  • High blood sugar and low albumin

When to get medical help

  • Call your care team if you have new or worse shortness of breath, chest pain, or swelling in your belly or bloating. These can signal fluid around the lungs or heart.
  • Report new or worsening swelling, rapid weight gain or severe dizziness. These can be signs of fluid buildup or capillary leak syndrome.
  • Seek help right away for fever, chills or other signs of infection. Serious and fatal infections have occurred.
  • Tell your doctor about a new or worsening skin rash, blisters or sunburn-like reactions.
  • Report signs of liver problems, as severe liver injury has occurred. Your doctor will check liver tests during treatment.
  • Tell your care team if the IV site becomes painful, swollen or irritated during the infusion.

Warnings and Precautions

  • Fluid buildup: effusions, edema and capillary leak syndrome can occur. Watch for shortness of breath, chest pain, belly swelling or weight gain.
  • Low blood counts: neutropenia, thrombocytopenia and anemia can be severe. Blood counts are checked throughout treatment.
  • Infections: serious and fatal infections have occurred.
  • Liver injury: liver tests are monitored, and treatment may be paused or stopped.
  • Skin reactions: avoid sun exposure and use protection.
  • Pregnancy: it can cause fetal harm.

Before You Start

  • Pregnancy: it can harm an unborn baby. Pregnancy testing is recommended before starting.
  • Contraception: use it for 10 months after the last dose (females) or 7 months (males with female partners who could become pregnant).
  • Breastfeeding: do not breastfeed during treatment and for 3 months afterward.
  • Male fertility may be affected.
  • Liver disease: avoid in severe impairment. Mild impairment needs closer monitoring.
  • Children: safety and effectiveness have not been established.
  • Older adults: no overall differences in safety or effectiveness were seen.

Half-Life and How Your Body Processes It

The antibody portion is expected to be broken down into small peptides. The cell-killing part (SG3199) is processed by the CYP3A4/5 enzymes in lab studies and is expected to be minimally cleared by the kidneys. The half-life is about 21 days at steady state, and steady state is reached after about 105 days. Age, sex, race, body weight and mild to moderate kidney impairment did not cause meaningful differences.

Storage

Store refrigerated at 2°C to 8°C (36°F to 46°F) in original carton to protect from light. Do not freeze.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Loncastuximab Tesirine-lpyl Injection

From the licensed clinical database we use, rolled up per supplement, most serious first.

38 supplements and herbal products have documented interactions with Loncastuximab Tesirine-lpyl Injection in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 29Moderate
  • 8Minor

See the other 30

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Loncastuximab Tesirine-lpyl Injection: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Loncastuximab Tesirine-lpyl Injection — the kind of thing our pharmacy team would talk through with you at the counter.

What is Zynlonta used for?

Zynlonta treats adults with large B-cell lymphoma that has come back or stopped responding after at least two earlier treatments. It targets a protein called CD19 on lymphoma cells. It was approved based on how many patients responded, so further studies are confirming its benefit.

How is Zynlonta given?

You get it as an IV infusion that takes about 30 minutes, once every 3 weeks. You will take a steroid called dexamethasone for 3 days, starting the day before each infusion. Your care team sets your dose and may adjust it if side effects occur.

What side effects should I expect?

Common ones include low blood counts, raised liver tests, tiredness, rash, swelling, nausea and muscle or bone pain. Your team will check blood work regularly. Call right away for fever, trouble breathing, chest pain, belly swelling or a worsening rash.

Do I need to avoid the sun on Zynlonta?

Yes. Zynlonta can cause sun sensitivity and other skin reactions. Limit direct sunlight, including through glass windows, and wear protective clothing or sunscreen. Tell your team about any new rash.

Can I take Zynlonta if I'm pregnant or breastfeeding?

No. It can harm an unborn baby, and a pregnancy test is recommended before you start. Use effective birth control during treatment and for 10 months afterward if you are female, or 7 months if you are a male with a partner who could become pregnant. Do not breastfeed during treatment or for 3 months after your last dose.

How long does Zynlonta stay in my body?

Its half-life is about 21 days at steady state, so it clears slowly. That is one reason monitoring and contraception continue after your last dose.

Is loncastuximab tesirine-lpyl injection available over the counter?

No. Loncastuximab tesirine-lpyl injection is a prescription medicine: every loncastuximab tesirine-lpyl injection product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was loncastuximab tesirine-lpyl injection first available?

The earliest FDA record we hold for loncastuximab tesirine-lpyl injection is from 2021: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when loncastuximab tesirine-lpyl injection was first used.

What is the brand name of loncastuximab tesirine-lpyl injection?

Loncastuximab tesirine-lpyl injection is the generic name. Its brand name is Zynlonta.

What is the generic name of Zynlonta?

The generic name of Zynlonta is loncastuximab tesirine-lpyl injection. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What strengths does loncastuximab tesirine-lpyl injection come in?

Loncastuximab tesirine-lpyl injection is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a vein): 10 mg/2 mL. A listing does not mean every pharmacy stocks every strength.

Where can I read the loncastuximab tesirine-lpyl injection prescribing information (package insert)?

The full FDA-approved prescribing information for loncastuximab tesirine-lpyl injection, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from ADC Therapeutics America, Inc.'s, revised Jun 12, 2026, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Loncastuximab Tesirine-lpyl Injection

Skip the scrolling. Ask in your own words and get an answer from Loncastuximab Tesirine-lpyl Injection’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Loncastuximab Tesirine-lpyl Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Loncastuximab Tesirine-lpyl Injection on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Loncastuximab Tesirine-lpyl Injection Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Loncastuximab Tesirine-lpyl Injection Forms and Strengths (How It Comes)

Loncastuximab Tesirine-lpyl Injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Loncastuximab Tesirine-lpyl Injection inactive ingredients by manufacturer.

Injection

Into a vein
Brands Zynlonta
How this form is used
What it may be used for
  • ZYNLONTA is used for adults with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.
Important instructions
  • ZYNLONTA is given as an intravenous infusion over 30 minutes.
  • ZYNLONTA is given on Day 1 of each 3-week cycle.
  • ZYNLONTA is prepared from a powder and diluted before infusion by trained staff.
  • ZYNLONTA is preceded by dexamethasone for 3 days, starting the day before, unless it is not appropriate.
Available strengths 1 strength
1 FDA-listed product record ⓘ

Loncastuximab Tesirine-lpyl Injection on the U.S. Market: Products, Makers and Brands

How Loncastuximab Tesirine-lpyl Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 1 Loncastuximab Tesirine-lpyl Injection product record with the FDA, mostly as injection; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Zynlonta; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
1
FDA-listed product records ⓘ
2021
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished injection, powder, lyophilized, for solution (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Loncastuximab Tesirine-lpyl Injection Is Used (Medicaid Data)

How many Loncastuximab Tesirine-lpyl Injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

32
Medicaid prescriptions filled (Q1–Q4 2025)
$91,029 paid by Medicaid, before rebates

How commonly is Loncastuximab Tesirine-lpyl Injection prescribed? Of the 1,682 medications we measure, Loncastuximab Tesirine-lpyl Injection ranks #1,644 by Medicaid prescriptions — more than 2% of them.

Where Loncastuximab Tesirine-lpyl Injection ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Loncastuximab Tesirine-lpyl Injection product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

loncastuximab tesirine-lpyl 10 MG Injection

32 Medicaid prescriptions (Q1–Q4 2025) 100% of Loncastuximab Tesirine-lpyl Injection prescriptions shown $91,029 paid by Medicaid, before rebates ≈ $2,845 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2540969

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 1 listed Loncastuximab Tesirine-lpyl Injection NDCs had Medicaid claims.

Compare Loncastuximab Tesirine-lpyl Injection Products

A representative set of FDA-listed product records for Loncastuximab Tesirine-lpyl Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Injection
10 mg/2 mL Intravenous ADC Therapeutics America, Inc. BLA View NDC →

Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Loncastuximab Tesirine-lpyl Injection NDCs →

Loncastuximab Tesirine-lpyl Injection Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Loncastuximab Tesirine-lpyl recalls since July 2021.

✅No Loncastuximab Tesirine-lpyl recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Loncastuximab Tesirine-lpyl Injection in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
1
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Loncastuximab Tesirine-lpyl Injection RxCUI 2540964
  1. Dose form (SCDF) Injection RxCUI 2540968
    In current FDA listings
    Its strength (SCD)
    • 10 mg lpyl RxCUI 2540969

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Loncastuximab Tesirine-lpyl Injection Brand Names

Loncastuximab Tesirine-lpyl Injection has one brand name on record: Zynlonta. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Zynlonta

Who Makes Loncastuximab Tesirine-lpyl Injection: Manufacturers and Labelers

One company lists Loncastuximab Tesirine-lpyl Injection products with the FDA. By number of product records, the largest are ADC Therapeutics America, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

ADC Therapeutics America, Inc. 1

Sources for This Loncastuximab Tesirine-lpyl Injection Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jun 12, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Loncastuximab Tesirine-lpyl Injection.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
1
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
ADC Therapeutics America, Inc.
Linked label effective
Jun 12, 2026
Composite sections available
21
Linked SPL Set ID
af54af12-3edf-4301-8bc5-0446bc813c1d
Linked SPL Document ID
6bd41585-62b9-4761-859b-759672bfd679
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. ADC Therapeutics America, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →